NovoCure NVCR Increase (Decrease) In Accounts Receivables And Prepaid Expenses
Increase (Decrease) In Accounts Receivables And Prepaid Expenses at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept nvcr:IncreaseDecreaseInAccountsReceivablesAndPrepaidExpenses.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's increase (decrease) in accounts receivables and prepaid expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's increase (decrease) in accounts receivables and prepaid expenses?
- NovoCure (NVCR) reported increase (decrease) in accounts receivables and prepaid expenses of -$828K in Q1 2026.
- How has NovoCure's increase (decrease) in accounts receivables and prepaid expenses changed year-over-year?
- NovoCure's increase (decrease) in accounts receivables and prepaid expenses decreased by 109.6% year-over-year, from $8.61M to -$828K.
- What is the long-term trend for NovoCure's increase (decrease) in accounts receivables and prepaid expenses?
- Over 3 years (2022 to 2025), NovoCure's increase (decrease) in accounts receivables and prepaid expenses has grown at a 148.2% compound annual growth rate (CAGR), from -$2.55M to $38.94M.
- What does increase (decrease) in accounts receivables and prepaid expenses mean?
- Measures the net change in the balance of amounts owed by customers for goods or services delivered and prepayments made to vendors during the reporting period. An increase in this balance typically indicates a use of cash due to extended credit terms or timing of payments, while a decrease reflects improved collection efficiency. Monitoring this metric is essential for assessing the company's working capital management and the quality of its revenue conversion cycle.